SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000190
Filing Date
2021-09-15
Accepted
2021-09-15 08:00:29
Documents
12
Period of Report
2021-09-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20210909.htm   iXBRL 8-K 42387
  Complete submission text file 0001485003-21-000190.txt   184812

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20210909.xsd EX-101.SCH 1914
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20210909_lab.xml EX-101.LAB 24993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20210909_pre.xml EX-101.PRE 13190
5 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20210909_htm.xml XML 11816
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211254278
SIC: 2834 Pharmaceutical Preparations